The Vanguard Group 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 5:31 pm Sale |
2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 2,932,399 2.220% |
-223,606 (-7.09%) |
Filing |
| 2025-02-07 5:31 pm Sale |
2025-01-31 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 2,932,399 2.220% |
-223,606 (-7.09%) |
Filing |
| 2024-11-12 4:59 pm Unchanged |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 3,156,005 9.040% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:30 pm Purchase |
2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 3,156,005 9.040% |
1,099,784 (+53.49%) |
Filing |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 2,056,221 5.980% |
2,056,221 (New Position) |
Filing |